A range of lipophilic prodrugs of α-carboxy nucleoside phosphonates, potent inhibitors of
HIV-1 reverse transcriptase without requiring prior phosphorylation,
were synthesized to evaluate their in vivo potency against HIV in
cell culture. A series of prodrug derivatives bearing a free carboxylic
acid where the phosphonate was masked with bispivaloyloxymethyl, diisopropyloxycarbonyloxymethyl,
bisamidate, aryloxyphosphoramidate, hexadecyloxypropyl, CycloSal,
and acycloxybenzyl moieties were synthesized, adapting existing methodologies
for phosphonate protection to accommodate the adjacent carboxylic
acid moiety. The prodrugs were assayed for anti-HIV activity in CEM
cell culturesthe bispivaloyloxymethyl free acid monophosphonate
prodrug exhibited some activity (inhibitory concentration-50 (IC50) 59 ± 17 μM), while the other prodrugs were inactive
at 100 μM. A racemic bispivaloyloxymethyl methyl ester monophosphonate
prodrug was also prepared to assess the suitability of the methyl
ester as a carboxylic acid prodrug. This compound exhibited no activity
against HIV in cellular assays.